Indication

Community acquired bacterial pneumonia

Community-acquired bacterial pneumonia is an acute infection of the pulmonary parenchyma contracted outside of healthcare settings by bacterial pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, or atypical organisms. Read more about Community acquired bacterial pneumonia

9 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Community acquired bacterial pneumonia therapies.

Showing 1–9 of 9 drugs

Filter & compare in the drug finder →Opens the drug finder with Community acquired bacterial pneumonia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Community acquired bacterial pneumonia.

Community-acquired bacterial pneumonia is an acute infection of the pulmonary parenchyma contracted outside of healthcare settings by bacterial pathogens such as *Streptococcus pneumoniae*, *Haemophilus influenzae*, or atypical organisms.

It predominantly affects the lower respiratory tract across pediatric and adult populations, with the highest morbidity and mortality occurring among older adults and individuals with cardiopulmonary comorbidities or immunocompromise.

Pathophysiologically characterized by alveolar inflammation, exudative consolidation, and impaired gas exchange, the condition typically manifests clinically with fever, productive cough, pleuritic chest pain, dyspnea, and demonstrable new infiltrates on chest imaging.

Personalize your experience

Follow Community acquired bacterial pneumonia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it